ELUT 株価分析 — Elutia Inc. (Healthcare >> Medical Devices)
ELUT に関するよくある質問
ELUTのPER(株価収益率)は?
Elutia Inc.(ELUT)は現在PER 0.54倍で取引されています。
ELUTのROE(自己資本利益率)は?
Elutia Inc.のROEは221.26%です。
ELUTの配当利回りは?
Elutia Inc.の配当利回りは0.00%です。
ELUTの品質スコア(Quality Score)は?
当社のAIはELUTの総合財務品質を100点中69点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。
ELUTは今が買い時ですか?
当社AIのタイミングスコアは100点中26点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。
ELUTはどのセクターに属しますか?
Elutia Inc.はHealthcare >> Medical Devicesセクターに分類されます(NASDAQ市場)
ELUT AI Analysis Summary
Our AI summary for ELUT: Elutia Inc. (NASDAQ), Healthcare >> Medical Devices sector. The stock currently trades at a P/E of 0.54, ROE of 221.26%, a dividend yield of 0.00%. Its financial Quality Score stands at 69/100 — mid-range fundamentals relative to the market. The AI Timing Score is 26/100 — most technical signals do not support an entry at this point. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.
|
USD 0.87
Price
0.01
(1.18%)
Day Change
|
|
|---|
ELUT, ファンダメンタルスコアはok ( ファンダメンタル = 69) そして テクニカルスコアは ...(Sign In to See)...
- Signal
- NEUTRAL
- Signal Description
- Company financial health is OK
- Reason
-
ROEの伸びが低い
ROAがROEに比べて低い
ROAの伸びが低い
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Momentum indicators aligned on the daily timeframe
In details, quality factors are good , financial health is not good , and ability to make profit is good , ...
| Deepscope 分析 |
|
70% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 97 |
| Magic Formula Rank by ROA |
12
GREAT
|
| Magic Formula Rank by ROE |
12
GREAT
|
| Magic Formula Rank by ROIC |
14
GREAT
|
| Price | 0.87 |
| PBV / Sector |
1.68 / -101.53
|
| Earning Per Share | 1.14 |
| PE / Sector |
0.54 / 31.42
GREAT
|
| PEG or PE/Growth / Sector |
-0.01 / 0.35
|
| Average 1M Daily Value |
0.09 M
GREAT
|
| Average 1W Daily Value |
0.06 M
GREAT
|
| Timing Factors |
|
14% |
| Financial Health |
|
41% |
| ポイントになる統計 |
|
72% |
| 配当 |
|
4% |
| 登録情報 |
| Analyze Date | 2026-08-04 08:01:27 |
| Symbol | ELUT |
| Name | ELUTIA INC. |
| Sector | Healthcare >> Medical Devices |
| Market | NASDAQ |
| Listed Shares | 44.21 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 37.88 / 20,008.89 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 20 Firstfield Road, Gaithersburg, MD, United States, 20878
Phone: 240 247 1170
Website: https://elutia.com
Sector: Healthcare >> Medical Devices
Description: Elutia Inc., a commercial-stage company, focuses on developing drug-eluting biomatrix products for use in surgical reconstruction and related applications. The company operates in two segments, Women's Health and Cardiovascular. Its lead development programs include NXT-41 and NXT-41x, which are designed as biologic scaffolds combined with local antibiotic delivery. The company provides SimpliDerm, a human acellular dermal matrix used in soft tissue reconstruction. It also offers ProxiCor for cardiac tissue repair for use as an intracardiac patch for repairs, such as atrial and ventricular septal defects and suture-line buttressing, and pledgets, as well as for pericardial closure to reconstruct the pericardium after heart surgery. In addition, the company provides Tyke, a thinner pliable matrix for the repair of pericardial structures for neonates and infants; as an epicardial for damaged or repaired cardiac structures; and as a patch material for cardiac defects, as well as VasCure, a patch material to repair or reconstruct the peripheral vasculature. The company sells its products directly to hospitals and other healthcare facilities through independent sales agents. The company was formerly known as Aziyo Biologics, Inc. and changed its name to Elutia Inc. in September 2023. Elutia Inc. was incorporated in 2015 and is headquartered in Gaithersburg, Maryland.
Analyst Ratings & Target Price
ME vs SECTOR Healthcare >> Medical Devices
Click a bubble to view stock details · Bubble size represents market capitalization share
Google